Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.32 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21147370 | 0.99 | KDM4E (0.40) | ATMKDM4EL3MBTL1PDE10AMEN1 | |
| SCHEMBL21146959 | 0.99 | KDM4E (0.40) | ATMKDM4EL3MBTL1PDE10AMEN1 | |
| SCHEMBL21147796 | 0.99 | KDM4E (0.40) | ATMKDM4EL3MBTL1PDE10AMEN1 | |
| SCHEMBL21146943 | 0.99 | ATM (0.40) | ATMKDM4EL3MBTL1PDE10AMEN1 | |
| SCHEMBL21147250 | 0.99 | KDM4E (0.40) | ATMKDM4EL3MBTL1PDE10AMEN1 | |
| SCHEMBL21147846 | 0.99 | KDM4E (0.40) | ATMKDM4EL3MBTL1PDE10AMEN1 | |
| SCHEMBL21147190 | 0.99 | KDM4E (0.40) | ATMKDM4EL3MBTL1PDE10AMEN1 | |
| SCHEMBL21147835 | 0.98 | ATM (0.41) | ATMKDM4EL3MBTL1PDE10AMEN1 | |
| SCHEMBL21147836 | 0.98 | ATM (0.41) | ATMKDM4EL3MBTL1PDE10AMEN1 | |
| SCHEMBL21147260 | 0.98 | ATM (0.41) | ATMKDM4EL3MBTL1PDE10AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11706977-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| US-11706977-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| US-11697645-B2 | Heterocyclic compound, composition including heterocyclic compound, and organic light-emitting device including heterocyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-07-11 | — | — | US | disclosed |
| US-11697645-B2 | Heterocyclic compound, composition including heterocyclic compound, and organic light-emitting device including heterocyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-07-11 | — | — | US | disclosed |
| US-20230140682-A1 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-05-04 | — | — | US | disclosed |
| US-20230140682-A1 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-05-04 | — | — | US | disclosed |
| US-11542252-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-01-03 | — | — | US | disclosed |
| US-20210184132-A1 | COMPOUND, COMPOSITION INCLUDING THE SAME, LIQUID COMPOSITION, AND ORGANIC ELECTROLUMINESCENT DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-06-17 | — | — | US | disclosed |
| US-20200207732-A1 | HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-07-02 | — | — | US | disclosed |
| US-20200207739-A1 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-07-02 | — | — | US | disclosed |
| US-20200212314-A1 | ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-07-02 | — | — | US | disclosed |
| US-20200212307-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-07-02 | — | — | US | disclosed |
| US-20190214570-A1 | HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11697645-B2 | Heterocyclic compound, composition including heterocyclic compound, and organic light-emitting device including heterocyclic compound | CYP1B1, CYP1A1, CCNT1 | ATM 1467/4885KDM4E 4155/4885L3MBTL1 517/4885 |
| US-11542252-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | CCNT1, CCNA1, CYP1B1 | ATM 1887/4885KDM4E 3931/4885L3MBTL1 175/4885 |
| US-11706977-B2 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | CRY1, CYP1B1, CYP1A1 | ATM 2932/4885KDM4E 2739/4885L3MBTL1 1990/4885 |
| US-20210184132-A1 | COMPOUND, COMPOSITION INCLUDING THE SAME, LIQUID COMPOSITION, AND ORGANIC ELECTROLUMINESCENT DEVICE | TERT, TELO2, POT1 | ATM 1487/4885KDM4E 1003/4885L3MBTL1 33/4885 |
| US-20200207732-A1 | HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND | CYP1B1, CYP1A1, CCNT1 | ATM 1467/4885KDM4E 4155/4885L3MBTL1 517/4885 |
| US-20230140682-A1 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | CCNT1, CCNA1, CYP1B1 | ATM 1887/4885KDM4E 3931/4885L3MBTL1 175/4885 |
| US-20190214570-A1 | HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND | CRY1, CYP1B1, CYP1A1 | ATM 2932/4885KDM4E 2739/4885L3MBTL1 1990/4885 |
| US-20200212307-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND | CCNB1, CCNA1, CCNT1 | ATM 827/4885KDM4E 4280/4885L3MBTL1 285/4885 |
| US-20200207739-A1 | Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound | CCNT1, CCNA1, CYP1B1 | ATM 1887/4885KDM4E 3931/4885L3MBTL1 175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.